Neutrophil gelatinase-associated lipocalin as a predictor of treatment outcomes in primary glomerulonephritis
Vojnosanitetski pregled · 2026 · 83 (4) · 208-217
DOI: 10.2298/vsp251026020s ↗Kurz gefasst
Fachartikel in der Zeitschrift Vojnosanitetski pregled, 2026. Verfasst von Gordana Strazmester-Majstorovic und 5 weiteren Autor:innen. Die Arbeit nennt 27 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-SA 4.0).
Abstract (Originalsprache)
Background/Aim. Biomarkers for predicting disease course could facilitate treatment selection in primary glomerulonephritis (PGN). Data on the role of neutrophil gelatinase-associated lipocalin (NGAL) in PGN are limited. The aim of this study was to evaluate the significance of NGAL in predicting treatment outcomes in PGN.
Methods
The study included a total of 60 PGN patients followed between 2012 and 2024. At diagnosis, serum NGAL (sNGAL) and urinary NGAL (uNGAL) were measured. Renal function parameters (serum creatinine, proteinuria) and disease outcome–development of end-stage renal disease (ESRD)–were assessed at baseline, after 5 years, and at the end of the follow-up period. The association between NGAL and clinical outcomes was analyzed using appropriate statistical tests.
Results
At baseline, median sNGAL and uNGAL levels were 154.71 ng/mL and 13.94 ng/mL, respectively. During a median follow-up of 112 months, 8.33% of patients were lost to follow-up, and 20% developed ESRD. Patients who developed ESRD had higher sNGAL levels (p = 0.027). Using sNGAL, ESRD was fairly predictive (AUC = 0.709; p = 0.036), and sNGAL was associated with time-to-ESRD (Kaplan-Meier analysis, p
Zitieren
APA
Strazmester-Majstorovic, G., Mitic, I., Djurovic, V., Golubovic, S., Petrovic, L., & Knezevic, V. (2026). Neutrophil gelatinase-associated lipocalin as a predictor of treatment outcomes in primary glomerulonephritis. Vojnosanitetski pregled, 83(4), 208-217. https://doi.org/10.2298/vsp251026020s
Vancouver
Strazmester-Majstorovic G, Mitic I, Djurovic V, Golubovic S, Petrovic L, Knezevic V. Neutrophil gelatinase-associated lipocalin as a predictor of treatment outcomes in primary glomerulonephritis. Vojnosanitetski pregled. 2026;83(4):208-217. doi:10.2298/vsp251026020s
BibTeX
@article{StrazmesterMajstorovic2026,
author = {Strazmester-Majstorovic, Gordana and Mitic, Igor and Djurovic, Vladimir and Golubovic, Sonja and Petrovic, Lada and Knezevic, Violeta},
title = {Neutrophil gelatinase-associated lipocalin as a predictor of treatment outcomes in primary glomerulonephritis},
journal = {Vojnosanitetski pregled},
year = {2026},
volume = {83},
number = {4},
pages = {208--217},
doi = {10.2298/vsp251026020s}
}
EUVIMED